- Home
- BLCO vs ATGE Comparison
BLCO vs ATGE Comparison
Compare BLCO & ATGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLCO
- ATGE
- Stock Information
- Founded
- BLCO 1853
- ATGE 1987
- Country
- BLCO Canada
- ATGE United States
- Employees
- BLCO N/A
- ATGE N/A
- Industry
- BLCO Ophthalmic Goods
- ATGE Other Consumer Services
- Sector
- BLCO Health Care
- ATGE Consumer Discretionary
- Exchange
- BLCO Nasdaq
- ATGE Nasdaq
- Market Cap
- BLCO 5.2B
- ATGE 5.4B
- IPO Year
- BLCO 2022
- ATGE 1991
- Fundamental
- Price
- BLCO $16.16
- ATGE $93.55
- Analyst Decision
- BLCO Hold
- ATGE Strong Buy
- Analyst Count
- BLCO 14
- ATGE 3
- Target Price
- BLCO $16.69
- ATGE $145.67
- AVG Volume (30 Days)
- BLCO 537.4K
- ATGE 940.5K
- Earning Date
- BLCO 10-29-2025
- ATGE 10-30-2025
- Dividend Yield
- BLCO N/A
- ATGE N/A
- EPS Growth
- BLCO N/A
- ATGE 53.29
- EPS
- BLCO N/A
- ATGE 6.69
- Revenue
- BLCO $4,976,000,000.00
- ATGE $1,833,178,000.00
- Revenue This Year
- BLCO $8.12
- ATGE $9.83
- Revenue Next Year
- BLCO $5.81
- ATGE $6.11
- P/E Ratio
- BLCO N/A
- ATGE $14.12
- Revenue Growth
- BLCO 6.23
- ATGE 12.24
- 52 Week Low
- BLCO $10.45
- ATGE $84.79
- 52 Week High
- BLCO $20.71
- ATGE $156.26
- Technical
- Relative Strength Index (RSI)
- BLCO 59.04
- ATGE 29.80
- Support Level
- BLCO $14.44
- ATGE $86.97
- Resistance Level
- BLCO $16.81
- ATGE $98.31
- Average True Range (ATR)
- BLCO 0.60
- ATGE 3.32
- MACD
- BLCO 0.02
- ATGE 0.87
- Stochastic Oscillator
- BLCO 72.15
- ATGE 55.38
About BLCO Bausch + Lomb Corporation
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
About ATGE Adtalem Global Education Inc.
Adtalem Global Education Inc is an American for-profit educational company that operates various university and educational programs. The company has three segments namely Chamberlain; Walden; and Medical and Veterinary. It derives maximum revenue from Chamberlain segment.